Please use this identifier to cite or link to this item:
|Title:||Mepolizumab and exacerbations of refractory eosinophilic asthma.|
|Citation:||N ENGL J MED, 2009, 360 (10), pp. 973-984|
|Abstract:||Exacerbations of asthma are associated with substantial morbidity and mortality and with considerable use of health care resources. Preventing exacerbations remains an important goal of therapy. There is evidence that eosinophilic inflammation of the airway is associated with the risk of exacerbations.|
|Appears in Collections:||Published Articles, Dept. of Infection, Immunity and Inflammation|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.